Clinical Trials Browser

Phase 1/2 × Enrolling by invitation × Radiotherapy, Intensity-Modulated × Clear all

NCT06890871 2025-03-24

Radiotherapy with Immunotherapy and Anti-Angiogenic Therapy for Advanced HER2-Negative Breast Cancer: a Single-Arm Study

Phase 1/2 Enrolling by invitation

Breast Neoplasms